Intech Investment Management LLC lifted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 127.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 173,478 shares of the health services provider's stock after purchasing an additional 97,180 shares during the period. Intech Investment Management LLC owned about 0.31% of Maximus worth $11,829,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd grew its stake in Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider's stock worth $36,000 after acquiring an additional 526 shares during the period. UMB Bank n.a. boosted its holdings in shares of Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider's stock valued at $41,000 after purchasing an additional 250 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock valued at $50,000 after purchasing an additional 294 shares during the last quarter. NBC Securities Inc. boosted its holdings in shares of Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider's stock valued at $78,000 after purchasing an additional 1,149 shares during the last quarter. Finally, Blue Trust Inc. boosted its holdings in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock valued at $84,000 after purchasing an additional 303 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.
Maximus Stock Down 0.6%
MMS stock traded down $0.55 during trading on Friday, reaching $89.54. The stock had a trading volume of 559,316 shares, compared to its average volume of 545,338. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.94. The company has a current ratio of 2.27, a quick ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market capitalization of $5.05 billion, a P/E ratio of 16.49 and a beta of 0.61. The firm has a fifty day moving average price of $79.89 and a 200 day moving average price of $73.15.
Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.77. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm's revenue was up 2.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.74 EPS. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. On average, equities analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.
Maximus Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Sunday, August 31st. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend was Friday, August 15th. Maximus's dividend payout ratio is currently 22.10%.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, Maximus has a consensus rating of "Strong Buy" and a consensus price target of $90.00.
Check Out Our Latest Stock Report on Maximus
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.